Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics in Cancer: A Hematological Perspective
Maximilian Stahl, Nathan Kohrman, Steven D. Gore, et al.
PLoS Genetics (2016) Vol. 12, Iss. 10, pp. e1006193-e1006193
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Cancer stem cells revisited
Eduard Batlle, Hans Clevers
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1124-1134
Open Access | Times Cited: 2341
Targeting Transcription Factors for Cancer Treatment
Mélanie Lambert, Samy Jambon, Sabine Depauw, et al.
Molecules (2018) Vol. 23, Iss. 6, pp. 1479-1479
Open Access | Times Cited: 310
Transcription Factors in Cancer Development and Therapy
Kanchan Vishnoi, Navin Viswakarma, Ajay Rana, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2296-2296
Open Access | Times Cited: 114
Precancer Atlas to Drive Precision Prevention Trials
Avrum Spira, Matthew B. Yurgelun, Ludmil B. Alexandrov, et al.
Cancer Research (2017) Vol. 77, Iss. 7, pp. 1510-1541
Open Access | Times Cited: 114
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
Gaia Giannone, Laura Attademo, Giulia Scotto, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1820-1820
Open Access | Times Cited: 83
Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
Jan Philipp Bewersdorf, Rory M. Shallis, Maximilian Stahl, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 77
Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations
Ramu Anandakrishnan, Robin Varghese, Nicholas A. Kinney, et al.
PLoS Computational Biology (2019) Vol. 15, Iss. 3, pp. e1006881-e1006881
Open Access | Times Cited: 77
The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance
Kangchen Chen, Chenzhi Zhang, Sunbin Ling, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 9
Open Access | Times Cited: 70
Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis
Bin Zhang, Jie Li, Yijun Wang, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 3, pp. 309-321
Open Access | Times Cited: 13
Epigenetics in pediatric acute lymphoblastic leukemia
Jessica Nordlund, Ann‐Christine Syvänen
Seminars in Cancer Biology (2017) Vol. 51, pp. 129-138
Open Access | Times Cited: 75
Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors
Rita Assi, Hagop M. Kantarjian, Farhad Ravandi, et al.
Current Opinion in Hematology (2017) Vol. 25, Iss. 2, pp. 136-145
Closed Access | Times Cited: 75
Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications
Maximilian Stahl, Amer M. Zeidan
Cancer (2017) Vol. 123, Iss. 10, pp. 1703-1713
Open Access | Times Cited: 51
Immune checkpoint molecules in acute myeloid leukaemia: managing the double‐edged sword
Willemijn Hobo, Tim J A Hutten, Nicolaas Schaap, et al.
British Journal of Haematology (2018) Vol. 181, Iss. 1, pp. 38-53
Open Access | Times Cited: 48
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
Yeuan Ting Lee, Yi Jer Tan, Marco Falasca, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2949-2949
Open Access | Times Cited: 42
Targeting Raf Kinase Inhibitory Protein Regulation and Function
Ali E. Yesilkanal, Marsha Rich Rosner
Cancers (2018) Vol. 10, Iss. 9, pp. 306-306
Open Access | Times Cited: 45
A call for action: Increasing enrollment of untreated patients with higher‐risk myelodysplastic syndromes in first‐line clinical trials
Amer M. Zeidan, Maximilian Stahl, Mikkael A. Sekeres, et al.
Cancer (2017) Vol. 123, Iss. 19, pp. 3662-3672
Open Access | Times Cited: 44
Points-to-consider on the return of results in epigenetic research
Stephanie O. M. Dyke, Katie M. Saulnier, Charles Dupras, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 39
miR‑148a, miR‑152 and miR‑200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression
Venhar Gürbüz, Sinan Sözen, Cenk Yücel Bilen, et al.
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 30
Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial Cancer
Karolina Frąszczak, Bartłomiej Barczyński
Cancers (2024) Vol. 16, Iss. 6, pp. 1083-1083
Open Access | Times Cited: 4
Exploring Epigenetic Complexity in Regulation of Hematopoietic Stem Cells Niche: A Mechanistic Journey from Normal to Malignant Hematopoiesis
Nur Afizah Yusoff, Zariyantey Abd Hamid, Izatus Shima Taib, et al.
Advances in experimental medicine and biology (2025)
Closed Access
MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells
Mei-Chuan Chen, Yuchen Lin, Yu-Hsuan Liao, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1617-1617
Open Access | Times Cited: 35
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review)
Ziqing Zhan, Xia Luo, Jiaxin Shi, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-15
Open Access
CD82 hypomethylation is essential for tuberculosis pathogenesis via regulation of RUNX1-Rab5/22
Hyun Jung Koh, Ye-Ram Kim, Jae‐Sung Kim, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 5, pp. 1-15
Open Access | Times Cited: 29
Differentiating between cancer and normal tissue samples using multi-hit combinations of genetic mutations
Sajal Dash, Nicholas A. Kinney, Robin Varghese, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29
TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC
Stacy Grieve, Gabriel Wajnberg, Miranda Lees, et al.
Blood Advances (2019) Vol. 3, Iss. 22, pp. 3613-3625
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top